Central Asia

Thermo Fisher's acquisition of Clario leads the clinical trial DX market. This guide details the strategic significance of M&A, market trends, implications for investors, and lessons to be learned by Japanese companies.

Huntington's acquisition of Cadence is a major M&A case in the U.S. financial industry: a detailed analysis of the strategic value of the $7.4 billion deal, its market impact, and future integration challenges.

Uzbekistan announces new tax incentives for foreign investors. This guide explains the country's economic reforms, investment incentives, market potential, and risks and opportunities. It provides an in-depth look at successful investment strategies in Central Asia.